Good evening :)
Switch to
Place Order

Neuland Laboratories Ltd

NEULANDLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,391 cr, stock is ranked 659
High RiskStock is 3.58x as volatile as Nifty
1,770.7593.15 (-5.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,391 cr, stock is ranked 659
High RiskStock is 3.58x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
29.66
PB RatioPB Ratio
3.04
Dividend YieldDiv. Yield
0.16%
Sector PESector PE
40.51
Sector PBSector PB
5.73
Sector Div YldSctr Div Yld
0.61%

Forecast & RatingsDetailed Forecast 

33%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates.

Investor PresentationView older 

Aug 3, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021531.94670.32766.60953.0112.0616.4416.2180.63
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Investor Presentation 
Announced OnAug 3, 2021

Neuland Laboratories Limited has informed the Exchange about Investor Presentation | Download

Neuland Laboratories Limited has informed the Exchange about Investor Presentation | Download

Press Release 
Announced OnAug 3, 2021

Neuland Laboratories Limited has informed the Exchange regarding a press release dated August 03, 2021, titled "Press Release". | Download

Neuland Laboratories Limited has informed the Exchange regarding a press release dated August 03, 2021, titled "Press Release". | Download

Cash Dividend 
Ex. DateJun 29, 2021

Final • Div/Share: ₹ 3

See all events